NBIX News and Press, Neurocrine Biosciences Inc. From 04/15/24

2024-04-15 06:38:19 ET More on smallcaps and midcaps IWM A Bargain As The S&P 500's P/E Hits 21x It's Selling Season For The Russell 2000 And ETFs That Track It IWM: Are Small Caps Being Overlooked In The Megacap Market Frenzy? Overbought conditions flash...

Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2024 Financial Results PR Newswire Conference Call and Webcast Scheduled for Wednesday, May 1 SAN DIEGO , April 10, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq...

Neurocrine Biosciences Announces First-Patient Dosed in Phase 2 Clinical Study Evaluating NBI-1070770 in Adults with Major Depressive Disorder PR Newswire SAN DIEGO , April 3, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced t...

2024-03-28 09:06:17 ET “Biotech industry has found its footing again”, says Karen Andersen – a Morningstar strategist. Here are the top U.S. based stocks within this space that are particularly worth owning for 2024. Vertex Pharmaceuticals Inc (NASDAQ: VRTX) ...

Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1065890, a Second-Generation VMAT2 Inhibitor, in Healthy Adults PR Newswire SAN DIEGO , March 28, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX), tod...

Neurocrine Biosciences to Participate at Virtual Investor Conferences in March PR Newswire UBS Virtual CNS Day 2024 Conference on March 18 Stifel 2024 Virtual CNS Days Conference on March 19 SAN DIEGO , March 11, 2024 /PRNewswire/ -- Neuro...

2024-02-24 08:00:00 ET Summary Vanguard S&P Mid-Cap 400 Growth Index Fund ETF Shares uses sales growth, earnings growth, and momentum to select stocks in the S&P Mid-Cap 400 Index. The VOG ETF overweights industrials and underweights financials compared to the parent index...

2024-02-16 13:50:39 ET More on Electronic Arts, Dave & Buster's, etc. Dave & Buster's: New Management, Promising Future Mayar Capital - Electronic Arts: Favorable Trends Coming Through  In The Financials Electronic Arts: Strong Cash Flows And Buybacks Ma...

2024-02-11 09:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-02-10 20:30:24 ET Summary Neurocrine Biosciences' shares have sold off post-earnings on concerns about its near-term opex spending and slowing growth for lead drug Ingrezza. Higher-than-expected opex spending includes targeted spending to grow the Ingrezza business (Huntingto...